Evidence map›Paper›PMID 29178082›Full record

ReviewBiophysical reviews2017

Conversion of microbial rhodopsins: insights into functionally essential elements and rational protein engineering.

Akimasa Kaneko, Keiichi Inoue, Keiichi Kojima, Hideki Kandori, Yuki Sudo

Open access · bronzeAbstract readReview
In one paragraph

Review in Biophysical reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Microbial Rhodopsins.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  6. Article
  7. Article
  8. Light-Controlled Mammalian Cells and Their Therapeutic Applications in Synthetic Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Akimasa KanekoFaculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan.
Keiichi InoueDepartment of Frontier Materials, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.
Keiichi KojimaGraduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
Hideki KandoriDepartment of Frontier Materials, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.
Yuki SudoFaculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan. sudo@okayama-u.ac.jp.ORCID http://orcid.org/0000-0001-8155-9356
Nagoya Institute of Technology · JPOkayama University · JPOkayama University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological progress has enabled the successful application of functional conversion to a variety of biological molecules, such as nucleotides and proteins. Such studies have revealed the functionally essential elements of these engineered molecules, which are difficult to characterize at the level of an individual molecule. The functional conversion of biological molecules has also provided a strategy for their rational and atomistic design. The engineered molecules can be used in studies to improve our understanding of their biological functions and to develop protein-based tools. In this review, we introduce the functional conversion of membrane-embedded photoreceptive retinylidene proteins (also called rhodopsins) and discuss these proteins mainly on the basis of results obtained from our own studies. This information provides insights into the molecular mechanism of light-induced protein functions and their use in optogenetics, a technology which involves the use of light to control biological activities.

Indexed as

Energy conversionMembrane proteinRetinalRhodopsinSignal transduction

Identifiers

PMID29178082
PMCPMC5711702
OpenAlexW2768495280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.